Reaction profile

The FDA adverse-event record for dysorexia

37 FDA reports name dysorexia, a lower-volume reaction in the CVM extract (VeDDRA 2271). Plate stamps and neighbourhood peers follow.

#1893 of 2,481
by report volume (all reactions)
37
reports citing this reaction
2.7%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Dysorexia has 37 reports now versus 31 in that prior snapshot: 6 more (19.4%).

Report change
+6
Death-coded reports
+0
Death-coded share
−0.5 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Dysorexia changes

FDA AER · VeDDRA plate

Code 2271 VOL-TRACE

VOL-TRACE · DEATH-LOW · LOWER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 37 reports
  • DEATH-LOW 2.7%
  • LOWER-Q #1893/2481
  • PHOTO-FINISH Blistering of mouth
  • SPECIES-DOG Dog · 31
  • DRUG-LEAD Trilostane · 18
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Blistering of mouth (±0 reports)

Instrument codes from this reaction’s FDA CVM adverse-event extract: volume band, death-coded share, corpus rank, photo-finish peer, lead species, lead drug, breed desk, and book completeness. Not a clinical diagnosis.

Lower-volume neighbourhood around Dysorexia

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Blistering of mouth · near37CARBON DIOXIDE HIGH,… · near37Cartilage degeneration · near37Cleft palate · near37Dysorexia · this reaction37Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Dysorexia

Dysorexia: low death-coded share in the FDA AER plate

Signature read: 1 death-coded reports is a thin tail count for Dysorexia in the CVM extract. Report volume is lower-third scale: 37 named reports in the openFDA extract. Death-coded share is lower-third: 1 of 37 reports (2.7% of named reports). Nearest volume peer: Blistering of mouth (±0 reports). Lead species Dog (31). Lead co-reported drug Trilostane (18).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Trilostane appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 31
Cat 5
Horse 1

Breeds Most Affected

Domestic Shorthair 5
Beagle 3
Shar Pei 3
Chihuahua 2
Terrier - Jack Russell 2
Shih Tzu 2
Terrier - Yorkshire 2
American Pit Bull Terrier 2
Dog (unknown) 2
Terrier - Bull - Staffordshire 1

Associated Drugs

Trilostane 18
Prednisone 6
Carprofen 5
Desoxycortone Pivalate 5
Grapiprant 3
Omeprazole 3
Bedinvetmab 3
Dexamethasone 3
Subcutaneous Fluids 3
Metabolic Diet 3
Glucosamine Chondroitin Sulfate 3
Sucralfate 3
Milbemycin Oxime + Spinosad 2
Verdinexor 2
Mirtazapine 2
Amlodipine 2
Pimobendan 2
Nystatin-Neomycin-Thiostrepton-Triamcinolone Acetonide 2
Ivermectin 1
Ivermectin(1.55%)/Praziquantel(7.75%) Paste 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Dysorexia (#1893 of 2,481 by report volume); death-coded 2.7%. PlainBreed reaction plate · death-coded report count stamp 1 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →